Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Smadja

Showing results (281-290 of 301) with videos related to

Pageof 31
Sort By:
Frontiers in Medicine|January 4, 2021
Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World SettingNicolas Gendron, Richard Chocron, Paul Billoir, et al.
The Journal of Experimental Medicine|December 20, 2023
A conserved transcriptional program for MAIT cells across mammalian evolutionHélène Bugaut, Yara El Morr, Martin Mestdagh, et al.
Research and Practice in Thrombosis and Haemostasis|March 24, 2025
Relevance of anti-platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemicNicolas Gendron, Dominique Helley, Johannes Thaler, et al.
Revue Des Maladies Respiratoires|July 9, 2019
[Recommendations for best practice in the management of venous thromboembolic disease in adults. Long version]O Sanchez, Y Benhamou, L Bertoletti, et al.
Angiogenesis|January 15, 2021
Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortalityAurélien Philippe, Richard Chocron, Nicolas Gendron, et al.
The British Journal of Dermatology|October 6, 2021
Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreakL Frumholtz, J-D Bouaziz, M Battistella, et al.
Journal of the American Heart Association|February 8, 2021
Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort StudyRichard Chocron, Vincent Galand, Joffrey Cellier, et al.
Archives of Cardiovascular Diseases|April 13, 2021
D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort studyRichard Chocron, Baptiste Duceau, Nicolas Gendron, et al.
Plos One|May 26, 2021
Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesityMarie-Agnès Dragon-Durey, Xiaoyi Chen, Amos Kirilovsky, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2021
Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital MortalityNicolas Gendron, Marie-Agnès Dragon-Durey, Richard Chocron, et al.
Pageof 31

Showing results (281-290 of 301) with videos related to

Sort By:
Pageof 31
Frontiers in Medicine|January 4, 2021
Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World SettingNicolas Gendron, Richard Chocron, Paul Billoir, et al.
The Journal of Experimental Medicine|December 20, 2023
A conserved transcriptional program for MAIT cells across mammalian evolutionHélène Bugaut, Yara El Morr, Martin Mestdagh, et al.
Research and Practice in Thrombosis and Haemostasis|March 24, 2025
Relevance of anti-platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemicNicolas Gendron, Dominique Helley, Johannes Thaler, et al.
Revue Des Maladies Respiratoires|July 9, 2019
[Recommendations for best practice in the management of venous thromboembolic disease in adults. Long version]O Sanchez, Y Benhamou, L Bertoletti, et al.
Angiogenesis|January 15, 2021
Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortalityAurélien Philippe, Richard Chocron, Nicolas Gendron, et al.
The British Journal of Dermatology|October 6, 2021
Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreakL Frumholtz, J-D Bouaziz, M Battistella, et al.
Journal of the American Heart Association|February 8, 2021
Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort StudyRichard Chocron, Vincent Galand, Joffrey Cellier, et al.
Archives of Cardiovascular Diseases|April 13, 2021
D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort studyRichard Chocron, Baptiste Duceau, Nicolas Gendron, et al.
Plos One|May 26, 2021
Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesityMarie-Agnès Dragon-Durey, Xiaoyi Chen, Amos Kirilovsky, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2021
Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital MortalityNicolas Gendron, Marie-Agnès Dragon-Durey, Richard Chocron, et al.
Pageof 31